Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682665 | PMC |
| http://dx.doi.org/10.1016/j.jdin.2023.07.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction: Changes in the skin microbiome in atopic dermatitis include a reduced bacterial diversity and increased abundance of Staphylococcus aureus. Topical antibiotics and antiseptics may decrease bacterial pathogens, but lack positive effects on microbiome diversity.
Methods: In this double-blind, intraindividual vehicle-controlled pilot study, n = 20 patients received a gel containing a defined extract (Spiralin®) of the microalgae Spirulina platensis, previously shown to exert anti-microbial effects, or vehicle on target lesions of similar size and clinical activity.
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis.
Dermatol Ther (Heidelb)
September 2025
Department of Dermatology, Kyoto University, Kyoto, Japan.
Atopic dermatitis (AD) is a chronic inflammatory disease characterized by eczematous skin lesions, intense pruritus, skin pain, sleep disruption, and mental health disturbances. There remains a need for a therapeutic option that delivers durable efficacy, safety, and convenient dosing across the AD patient population. This review provides an overview of AD pathogenesis driven by T-cell imbalance and describes a novel therapeutic option targeting the OX40 receptor, a costimulatory molecule expressed specifically on activated T cells.
View Article and Find Full Text PDFOutpatient and Inpatient Management of Infants and Children With Eczema Herpeticum Diagnosed in the Emergency Department.
Pediatr Dermatol
September 2025
Department of Pediatrics, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, USA.
Background: There are no universally established guidelines for when pediatric EH warrants hospitalization or intravenous (IV) acyclovir over oral therapy. To address this lack of consensus, this study aimed to describe outcomes of outpatient oral acyclovir treatment in pediatric EH cases, including rates of disease exacerbation, hospitalizations, and complications.
Methods: We conducted a retrospective cohort review of pediatric patients under age 7 diagnosed with EH who presented to the pediatric emergency department (ED) between January 1, 2008, and December 31, 2022.
Atopic dermatitis, hypertension, and cardiovascular risk: an appraisal of the evidence.
Ital J Dermatol Venerol
September 2025
Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Atopic dermatitis is the most common chronically or chronically relapsing inflammatory skin disease, characterized by intense pruritus, eczematous lesions, and a significant disease burden. Emerging evidence in recent years suggests that atopic dermatitis and the associated chronic systemic inflammation have health implications beyond the skin. For psoriasis, another chronic inflammatory skin disease, the association with cardiovascular diseases (CVDs) is well-established.
View Article and Find Full Text PDFEfficacy of abrocitinib in patients with moderate-to-severe head and neck dermatitis.
J Am Acad Dermatol
September 2025
Kunming Medical University. No.1168 Chunrong West Road, Kunming, China; The First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming, China. Electronic address: